Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
CMS Recovery Thresholds Update
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
Article
CMS Recovery Thresholds Update
Keep current with new legislation and its potential effect on your organization.
Mitchell
News Release
Five Ways Mitchell Cloud Glass is Simplifying the Evolving Challenges of Glass Claims
Glass claims have grown increasingly complex over the past few years, and it appears that even more complexity lies ahead.
Workers' Comp
Blog
Overview of the 2019 Texas Department of Insurance Workers’ Compensation Network Report Card
The Texas Department of Insurance recently released its annual Workers’ C
Mitchell
News Release
Mitchell l Genex Acquires CompAlliance, Expanding and Enhancing Managed Care Services
SAN DIEGO, CA—Mitchell | Genex, a leader in technology solutions, medical cost containment and disability management has announced
Workers' Comp
News Release
Mitchell | Genex Acquires CompAlliance, Expanding and Enhancing Managed Care Services
Deal to provide more robust medical cost containment and clinical solutions for workers' compensation industry San Diego, CA - De